To authorize the levels of production and consumption necessary to satisfy essential uses of CFCs for metered-dose inhalers for asthma and chronic obstructive pulmonary diseases as well as for laboratory and analytical uses as specified in annex I to the present report, subject to the conditions established by the Meeting of the Parties in paragraph 2 of its decision VII/28;
Declaración del Presidente de la 14ª Reunión de las Partes en el Protocolo de Montreal relativo a las sustancias que agotan la capa de ozono